
Female heart attack survivors sometimes benefit more from cardiac resynchronization therapy plus defibrillator implantation (CRT-D) compared to men though they are less likely to receive the therapy, a new study led by Robbert Zusterzeel at Center for Devices and Radiological Health at the U.S. Food and Drug Administration reveals. Background: Women are underrepresented in CRT trials for heart failure, making up only about 20 percent of participants. In selected ...
Read More
No comments:
Post a Comment